Skip to Main Content

Author Details

Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
1990
140
36
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36727449The impact of nucleosome structure on CRISPR/Cas9 fidelity.Nucleic Acids Res2023
37577456The Role of C-to-U RNA Editing in Human Biodiversity.bioRxiv2023
37258909Computational Grafting of Epitopes.Methods Mol Biol2023
37180722Effective holistic characterization of small molecule effects using heterogeneous biological networks.Front Pharmacol2023
36645300Antiviral Approaches against Influenza Virus.Clin Microbiol Rev2023
36674513Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer.Int J Mol Sci2023
34400352Evaluating the performance of drug-repurposing technologies.Drug Discov Today2022
35631392Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease.Pharmaceuticals (Basel)2022
35566372Identifying Protein Features and Pathways Responsible for Toxicity Using Machine Learning and Tox21: Implications for Predictive Toxicology.Molecules2022
36091793Optimal COVID-19 therapeutic candidate discovery using the CANDO platform.Front Pharmacol2022
35111726Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK.Front Chem2022
34172723Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.Nat Commun2021
33925237Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.Molecules2021
33689684A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex.Cell Chem Biol2021
34959678A Deep-Learning Proteomic-Scale Approach for Drug Design.Pharmaceuticals (Basel)2021
34626674A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition.Antiviral Res2021
32511286Shotgun drug repurposing biotechnology to tackle epidemics and pandemics.ChemRxiv2020
32069042CANDOCK: Chemical Atomic Network-Based Hierarchical Flexible Docking Algorithm Using Generalized Statistical Potentials.J Chem Inf Model2020
32570644Linking Genome and Exposome: Computational Analysis of Human Variation in Chemical-Target Interactions.Stud Health Technol Inform2020
32570581Association of C>U RNA Editing with Human Disease Variants.Stud Health Technol Inform2020
32515949cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug-Protein-Disease Data.J Chem Inf Model2020
32405249Shotgun drug repurposing biotechnology to tackle epidemics and pandemics.Drug Discov Today2020
32254053Rv0100, a proposed acyl carrier protein in Mycobacterium tuberculosis: expression, purification and crystallization. Corrigendum.Acta Crystallogr F Struct Biol Commun2020
30621144Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design.Molecules2019
31656912Fingerprinting CANDO: Increased Accuracy with Structure- and Ligand-Based Shotgun Drug Repurposing.ACS Omega2019
31584013Rv0100, a proposed acyl carrier protein in Mycobacterium tuberculosis: expression, purification and crystallization.Acta Crystallogr F Struct Biol Commun2019
31174591Exploration of interaction scoring criteria in the CANDO platform.BMC Res Notes2019
31511563Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications.Sci Rep2019
30277763Photochemistry of the 1,6-Dideuterio-1,3,5-hexatrienes in Solution: Efficient Terminal Bond Photoisomerization in One-Bond-Twist and Bicycle Pedal Ways.J Phys Chem A2018
29053626A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment.Molecules2017
27013226Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.Curr Pharm Des2016
27898018Combating Ebola with Repurposed Therapeutics Using the CANDO Platform.Molecules2016
27146385Mycobacterium Cytidylate Kinase Appears to Be an Undruggable Target.J Biomol Screen2016
25694071Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.Mini Rev Med Chem2015
26556362Composite Sequence-Structure Stability Models as Screening Tools for Identifying Vulnerable Targets for HIV Drug and Vaccine Development.Viruses2015
24532722fast_protein_cluster: parallel and optimized clustering of large-scale protein modeling data.Bioinformatics2014
25625010Data access for the 1,000 Plants (1KP) project.Gigascience2014
24980786CANDO and the infinite drug discovery frontier.Drug Discov Today2014
23497186Homo-dimerization and ligand binding by the leucine-rich repeat domain at RHG1/RFS2 underlying resistance to two soybean pathogens.BMC Plant Biol2013
30338132The Promise and Challenge of Digital Biology.J Bioeng Biomed Sci2013
23904008Bicycle pedal photoisomerization of 1-phenyl-4-(4-pyridyl)-1,3-butadienes in glassy isopentane at 77 K.Photochem Photobiol Sci2013
23867606Structure prediction of partial-length protein sequences.Int J Mol Sci2013
24023924Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin.PLoS One2013
22899687Strategic protein target analysis for developing drugs to stop dental caries.Adv Dent Res2012
22970111The enzymatic and metabolic capabilities of early life.PLoS One2012
22974364Self-assembly of filamentous amelogenin requires calcium and phosphate: from dimers via nanoribbons to fibrils.Biomacromolecules2012
23051043Synthesis of donor-Ï¿-perylenebisimide-acceptor molecules having PEG swallowtails and sulfur anchors.J Org Chem2012
22718788Accelerated protein structure comparison using TM-score-GPU.Bioinformatics2012
22743342Cementomimetics-constructing a cementum-like biomineralized microlayer via amelogenin-derived peptides.Int J Oral Sci2012
20974833Computational prediction of type III and IV secreted effectors in gram-negative bacteria.Infect Immun2011
  • 1 - 50 of 140

Recommended Authors

Institute of Structural and Molecular Biology, University College London
Career Start Year 2017
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 3
University of Kent
Career Start Year 2007
Number of shared co-authors 1
University of Minnesota
Career Start Year 2003
Number of shared co-authors 0
Worcester Polytechnic Institute
Career Start Year 2002
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 4
Institute of Biological, Aberystwyth University
Career Start Year 2002
Number of shared co-authors 1
Stanford University
Career Start Year 1999
Number of shared co-authors 3
Osaka university
Career Start Year 1998
Number of shared co-authors 6
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year 1997
Number of shared co-authors 2
Purdue University
Career Start Year 1997
Number of shared co-authors 3
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 5
Indian Institute of Science Education and Research Pune
Career Start Year 1996
Number of shared co-authors 2
University of California berkeley
Career Start Year 1994
Number of shared co-authors 5
Technical University of Munich (TUM)
Career Start Year 1992
Number of shared co-authors 6
Universitat Pompeu Fabra
Career Start Year 1991
Number of shared co-authors 1
Heidelberg University
Career Start Year 1991
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 6
National University of Singapore
Career Start Year 1987
Number of shared co-authors 0
University of California Riverside
Career Start Year 1987
Number of shared co-authors 5
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 1
University of Virginia
Career Start Year 1980
Number of shared co-authors 4
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 3
Imperial College London
Career Start Year 1976
Number of shared co-authors 1
VIB-VUB Center for Structural Biology
Career Start Year 1975
Number of shared co-authors 3
National Center for Biotechnology Information
Career Start Year 1973
Number of shared co-authors 5
Macquarie University
Career Start Year 1972
Number of shared co-authors 3
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 6
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 2

Collaborators

Pacific Northwest National Laboratory
Co-authored papers 15
Director of Clinical Innovation
Co-authored papers 12
Stanford University
Co-authored papers 8
Institute for Bioscience and Biotechnology Research
Co-authored papers 5
Beijing Institute of Genomics, Chinese Academy of Sciences
Co-authored papers 4
College of Information Engineering, Zhejiang University of Technology
Co-authored papers 4
Zhongnan Hospital of Wuhan University
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Institute of Medical Research, Northwestern Polytechnical University
Co-authored papers 3
Experimental Research Center, China Academy of Chinese Medical Sciences
Co-authored papers 3
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 2
Institute for Frontier Materials, Deakin University
Co-authored papers 2
The Second Hospital, Jilin University
Co-authored papers 2
University of Washington
Co-authored papers 2
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Co-authored papers 1
University of Washingtongrid.34477.33
Co-authored papers 1
Institute of Biomedical Sciences, Henan Academy of Sciences
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Washington
Co-authored papers 1
Washington University School of Medicine in St. Louis
Co-authored papers 1
Yale University
Co-authored papers 1
State University of New York at Buffalo
Co-authored papers 1
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 1
Purdue University
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of Florida
Co-authored papers 1